vimarsana.com

Page 89 - நாஸ்டாக் உலகளாவிய தேர்ந்தெடுக்கவும் சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aurora Cannabis to Begin Trading on the The Nasdaq Global Select Market on May 25, 2021 at Market Open

Aurora Cannabis to Begin Trading on the The Nasdaq Global Select Market on May 25, 2021 at Market Open News provided by Share this article Company or Aurora ) (NASDAQ | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced that it has completed the transfer of its stock exchange listing to The Nasdaq Global Select Market ( Nasdaq ) from the New York Stock Exchange ( NYSE ) after the market close today. The Company s common stock will begin trading as a Nasdaq-listed security at market open on May 25, 2021 and will continue to be listed under the ticker symbol ACB. This transition does not impact the Company s primary listing on the Toronto Stock Exchange (TSX: ACB). Aurora shareholders DO NOT need to take any further action.

Rule 2 5 Announcement: Xeris Pharmaceuticals, Inc to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases

Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION THIS ANNOUNCEMENT IS BEING MADE PURSUANT TO RULE 2.5 OF THE IRISH TAKEOVER RULES FOR IMMEDIATE RELEASE Transaction Creates Fast-Growing Biopharmaceutical Company with Two Commercial Assets and Robust Clinical Pipeline with Multiple Near-term Inflection Points Diversifies Revenue Base with Two Rapidly Growing Brands in Xeris Gvoke® and Strongbridge s KEVEYIS®

SEC approves Nasdaq direct listing proposal

SEC approves Nasdaq direct listing proposal Print The Securities and Exchange Commission approved a Nasdaq proposal allowing companies to raise capital while also doing direct listings instead of initial public offerings. Nasdaq initially submitted the proposal in September, but after the SEC expressed concern with it in December, Nasdaq amended the proposal in February, and the SEC approved it in an order dated May 19. Unlike IPOs, direct listings allow companies to participate in the stock market without selling new shares, and with fewer restrictions and fees. Prior to approving a similar proposal from the New York Stock Exchange in December, the SEC did not allow companies to raise new capital while going through the direct listing process.

Xeris Pharmaceuticals, Inc to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases

Xeris Pharmaceuticals, Inc to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.